UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-42907
Charming Medical Limited
(Translation of registrant’s name into English)
Units 1803-1806, 18/F, Hang Lung Centre
2-20 Paterson Street, Causeway Bay, Hong Kong
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
In connection with an extraordinary general meeting of shareholders of Charming Medical Limited (the “Company”), attached hereto and incorporated by reference herein are the Notice of Extraordinary General Meeting, the Proxy Statement, and Form of Proxy Card for the Extraordinary General Meeting.
| 1 |
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Notice of Extraordinary General Meeting and Proxy Statement | |
| 99.2 | Form of Proxy Card for the Extraordinary General Meeting |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: September 29, 2026 | Charming Medical Limited | |
| By: | /s/ Kit Wong | |
| Name: | Kit Wong | |
| Title: | Chief Executive Officer and Chairman of the Board of Directors | |
| 3 |